    Vaughn Himes | Seattle Genetics , Inc. | ZoomInfo.com 



Seattle Genetics Announces Executive Promotions and Leadership Appointment | Business Wire
























































Seattle Genetics Announces Executive Promotions and Leadership 
      Appointment




-Vaughn B. Himes, Ph.D., Promoted to Chief Technical Officer-


-Dennis Benjamin, Ph.D., Promoted to Senior Vice President, 
      Translational Research-


-Robert J. Lechleider, M.D., Named Senior Vice President, Clinical 
      Development-






October 04, 2016 08:00 AM Eastern Daylight Time



BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) today announced two executive 
      promotions and an executive appointment to the company’s clinical 
      development leadership team.
    


      Vaughn B. Himes, Ph.D., has been promoted to Chief Technical Officer. In 
      this new role, he will oversee Seattle Genetics’ process sciences, 
      manufacturing, supply chain, quality assurance and quality control 
      functions. Dennis Benjamin, Ph.D., has been promoted to Senior Vice 
      President, Translational Research. Dr. Benjamin will be responsible for 
      preclinical research, nonclinical sciences and experimental 
      pharmacology. Seattle Genetics also named Robert J. Lechleider, M.D., as 
      Senior Vice President, Clinical Development. Dr. Lechleider will oversee 
      all clinical development programs within the company’s therapeutic focus 
      areas of lymphoma, leukemia, solid tumors, and immuno-oncology, as well 
      as translational medicine and biometrics.
    

      “The promotions of Dr. Himes and Dr. Benjamin, along with the 
      appointment of Dr. Lechleider, continue to reinforce the strength of 
      Seattle Genetics as we transition to a multi-product, global 
      organization,” said Clay Siegall, Ph.D., President and Chief Executive 
      Officer.
    

      Vaughn B. Himes joined Seattle Genetics in April 2009, bringing more 
      than twenty years of experience in manufacturing, technical operations, 
      process development and scale-up activities. He most recently served as 
      Executive Vice President, Process Sciences and Technical Operations. 
      Prior to joining Seattle Genetics, Dr. Himes was with ZymoGenetics as 
      Senior Vice President, Technical Operations, where his responsibilities 
      included commercial and clinical manufacturing, supply chain and 
      logistics, quality control and process development. Dr. Himes received a 
      B.A. in Chemistry from Pomona College and a Ph.D. in Chemical 
      Engineering from the University of Minnesota.
    

      “Vaughn has played a critical role in the growth of our company and has 
      been a vital member of the executive team for many years,” said Eric 
      Dobmeier, Chief Operating Officer. “His vision and expertise in the 
      areas of process sciences, technical operations and manufacturing will 
      continue to help us advance our therapies to patients in need.”
    

      Dennis Benjamin joined Seattle Genetics in December 2004, starting as 
      Director of Biochemistry and working his way through various positions 
      within research to his current role as Senior Vice President, 
      Translational Research. Prior to joining Seattle Genetics, he held 
      research positions at Praecis Pharmaceuticals and Genetics Institute. 
      Dr. Benjamin received a B.S. in Chemistry from the Massachusetts 
      Institute of Technology and a Ph.D. in Medicinal Chemistry from the 
      University of California, San Francisco. He also completed a 
      Post-Doctoral Fellowship at the University of Oxford.
    

      “Dennis has built strong scientific teams who have driven promising 
      programs through early- and late-stage research, enabling Seattle 
      Genetics to have a robust pipeline that positions us for continued 
      success,” says Jonathan Drachman, M.D., Chief Medical Officer and 
      Executive Vice President of Research and Development. “He has shown 
      tremendous commitment to bringing innovative, promising therapies to 
      patients through our industry-leading ADC technology platform.”
    

      Robert J. Lechleider, M.D., recently joined Seattle Genetics as Senior 
      Vice President, Clinical Development. Previously, Dr. Lechleider held 
      key roles at several biopharmaceutical companies, including MacroGenics 
      and MedImmune. Before joining the biotechnology industry, he served as 
      Assistant Professor of Pharmacology at Uniformed Services University of 
      the Health Sciences, and Associate Professor of Cell Biology at 
      Georgetown University Medical School. Dr. Lechleider received his A.B. 
      cum laude from Princeton University and his M.D. from the University of 
      Illinois College of Medicine at Chicago. He received clinical training 
      in internal medicine at Beth Israel Hospital in Boston and in medical 
      oncology at the National Cancer Institute in Bethesda. He was also a 
      Howard Hughes Medical Institute Scholar and a Damon Runyon-Walter 
      Winchell postdoctoral fellow.
    

      “Dr. Lechleider brings a wealth of clinical and biotechnology experience 
      which will help Seattle Genetics continue to fulfill its mission of 
      improving the lives of people with cancer around the world, and keep us 
      at the forefront of scientific excellence,” added Dr. Drachman. “We are 
      pleased to have Bob join the company as the head of Clinical Development 
      where he will oversee the development of ADCETRIS and more than 10 
      programs in our growing oncology pipeline.”
    

About Seattle Genetics


      Seattle Genetics is an innovative biotechnology company that develops 
      and commercializes novel antibody-based therapies for the treatment of 
      cancer. The company’s industry-leading antibody-drug conjugate (ADC) 
      technology harnesses the targeting ability of antibodies to deliver 
      cell-killing agents directly to cancer cells. ADCETRIS® (brentuximab 
      vedotin), the company’s lead product, in collaboration with Takeda 
      Pharmaceutical Company Limited, is the first in a new class of ADCs 
      commercially available globally in 65 countries for relapsed classical 
      Hodgkin lymphoma (HL) and relapsed systemic anaplastic large cell 
      lymphoma (sALCL). Seattle Genetics is also advancing vadastuximab 
      talirine (SGN-CD33A; 33A), an ADC in a phase 3 trial for acute myeloid 
      leukemia. Headquartered in Bothell, Washington, Seattle Genetics is also 
      advancing a robust pipeline of innovative therapies for blood-related 
      cancers and solid tumors designed to address significant unmet medical 
      needs and improve treatment outcomes for patients. The company has 
      collaborations for its proprietary ADC technology with a number of 
      companies including AbbVie, Astellas, Bayer, Celldex, Genentech, 
      GlaxoSmithKline and Pfizer. More information can be found at www.seattlegenetics.com.
    




Contacts

      Seattle Genetics, Inc.Investors:Peggy Pinkston, 425-527-4160ppinkston@seagen.comorMedia:Brandi 
      Robinson, 425-527-2910brobinson@seagen.com



















$Cashtags

$SGEN





Contacts

      Seattle Genetics, Inc.Investors:Peggy Pinkston, 425-527-4160ppinkston@seagen.comorMedia:Brandi 
      Robinson, 425-527-2910brobinson@seagen.com









 
 

 






Search




Advanced News Search

Advanced News Search













Log In
Sign Up












Vaughn B. Himes, Sr. VP, Technical Operations, ZymoGenetics Inc.














A publisher of Business Information since 1983   
  





 


   

Search Business Search Executive 
  Advanced Search 




  

Sign In  |  Hints 









Profile of Vaughn Himes 





 


Vaughn Himes

 

Sr. VP, Technical Operations - ZymoGenetics Inc.

 


Vaughn Himes Email :
Please login 

 

Company Name : 
ZymoGenetics Inc. 

 

Company Website : 
www.zymogenetics.com 

 

Company Address : 
1201 Elake Ave. E, Seattle, WA,United States, 


 


Vaughn Himes Profile :
Sr. VP, Technical Operations - ZymoGenetics Inc. 

 


Vaughn Himes Biography :


Dr. Himes was appointed Senior Vice President Technical Operations in May 2006. Dr. Himes joined ZymoGenetics in November 2005 as Vice President Commercial Manufacturing Operations. Previously Dr. Himes served as Vice President for Worldwide Manufacturing Operations for Corixa Corporation with responsibility for manufacturing operations process development and quality control in support of commercial and clinical supplies. From 2000 to 2003 Dr. Himes served as Vice President Manufacturing Operations for Targeted Genetics Corporation where he was responsible for manufacturing and clinical supply operations for gene delivery products. From 1999 to 2000 Dr. Himes served as Vice President Product Development for Genovo Inc. Prior to that Dr. Himes held positions of increasing responsibility over ten years with Wyeth-Lederle Vaccines including Associate Director of Biological Development Manager of Viral Vaccine Development and Clinical Production and Cell Culture Pilot Plant Supervisor. Dr. Himes received a Bachelors of Arts in Chemistry from Pomona College in California and a Ph.D. in Chemical Engineering from the University of Minnesota. 

 


Vaughn Himes Colleagues :





Name 
Title 
Email 


Lars Sorensen 
Board Dir. 
Please login 


David Hirsh 
Board Dir. 
Please login 


Suzanne Shema 
Sr. VP, General Counsel, Law, Compliance 
Please login 


Bruce Carter 
Chmn., Pres., CEO 
Please login 


James Harper 
Board Dir. 
Please login 













            Home  |  About Us  |  Product Information   |  Subscription  |  List Builder   |  Executive List   |  Email Lists   |  Contact Us  |  Site Map  |  Browse Directory    





 

© 2009, Walkers's Research - A publisher of Business Information since 1983, All Rights Reserved.






SGEN Vaughn B. Himes Insider Trades for Seattle Genetics Inc.


































Bulletin






Investor Alert





















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Seattle Genetics Inc.

                  NASDAQ: SGEN
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Seattle Genetics Inc.



After Hours
 --Quotes are delayed by 20 min
Jul 28, 2017, 4:11 p.m.


SGEN

/quotes/zigman/85432/composite


$
51.18




Change

+0.0033
+0.0064%

Volume
Volume 13,483
Quotes are delayed by 20 min








/quotes/zigman/85432/composite
Today's close

$
			52.97
		


$
				51.18
			
Change

-1.79
-3.38%





Day low
Day high
$50.16
$54.00










52 week low
52 week high

            $42.58
        

            $75.36
        


















Insider Activity


Individual




Vaughn B. Himes



Dr. Vaughn B. Himes is Chief Technology Officer at Seattle Genetics, Inc. Dr. Himes was previously employed as Senior Vice President-Technical Operations by ZymoGenetics, Inc., Vice President-Worldwide Manufacturing by Corixa Corp., Vice President-Manufacturing Operations by Targeted Genetics Corp., and Vice President-Product Development by Genovo, Inc. He received his undergraduate degree from Pomona College and a doctorate degree from the University of Minnesota.



Transactions


Date
Shares
Transaction
Value





05/31/2017
9,400


 
Disposition at $62.54 per share.


587,876


05/31/2017
9,400


 
Derivative/Non-derivative trans. at $9.23 per share.


86,762


05/31/2017
600


 
Disposition at $63.41 per share.


38,046


05/31/2017
600


 
Derivative/Non-derivative trans. at $9.23 per share.


5,538


03/31/2017
10,000


 
Disposition at $62.75 per share.


627,500


03/31/2017
10,000


 
Derivative/Non-derivative trans. at $9.23 per share.


92,300


12/12/2016
5,333


 
Derivative/Non-derivative trans. at $12 per share.


63,996


12/12/2016
6,468


 
Derivative/Non-derivative trans. at $15.46 per share.


99,995


12/12/2016
3,831


 
Derivative/Non-derivative trans. at $26.1 per share.


99,989


12/07/2016
1,427


 
Disposition at $66.08 per share.


94,297


12/07/2016
28,573


 
Disposition at $65.29 per share.


1,865,532


12/07/2016
30,000


 
Derivative/Non-derivative trans. at $9.23 per share.


276,900


08/31/2016
9,600


 
Award at $0 per share.


0


08/27/2016
17,000


 
Award at $0 per share.


0


08/22/2016
3,991


 
Disposition at $46.59 per share.


185,941


12/18/2015
32,036


 
Derivative/Non-derivative trans. at $9.23 per share.


295,692


12/18/2015
3,000


 
Derivative/Non-derivative trans. at $12 per share.


36,000


12/15/2015
40,500


 
Disposition at $39.94 per share.


1,617,570


12/15/2015
40,500


 
Derivative/Non-derivative trans. at $9.23 per share.


373,815


08/25/2015
15,000


 
Award at $0 per share.


0


08/20/2015
5,997


 
Disposition at $42.02 per share.


251,994


03/12/2015
20,000


 
Disposition at $36.65 per share.


733,000


03/12/2015
20,000


 
Derivative/Non-derivative trans. at $9.23 per share.


184,600


11/12/2014
10,000


 
Disposition at $37.52 per share.


375,200


11/12/2014
10,000


 
Derivative/Non-derivative trans. at $9.23 per share.


92,300


08/26/2014
15,000


 
Award at $0 per share.


0


08/24/2014
3,310


 
Disposition at $43.55 per share.


144,151


05/09/2014
10,000


 
Disposition at $35 per share.


350,000


05/09/2014
10,000


 
Derivative/Non-derivative trans. at $9.23 per share.


92,300


02/28/2014
11,300


 
Derivative/Non-derivative trans. at $9.23 per share.


104,299


02/19/2014
2,088


 
Disposition at $52.01 per share.


108,597


02/19/2014
3,000


 
Disposition at $52.01 per share.


156,030


02/19/2014
3,000


 
Derivative/Non-derivative trans. at $9.23 per share.


27,690


08/19/2013
14,400


 
Award at $0 per share.


0


08/19/2013
1,736


 
Disposition at $40.91 per share.


71,020


06/13/2013
10,000


 
Disposition at $32.11 per share.


321,100


06/13/2013
10,000


 
Derivative/Non-derivative trans. at $9.23 per share.


92,300


09/10/2012
10,000


 
Disposition at $28.79 per share.


287,900


09/10/2012
10,000


 
Derivative/Non-derivative trans. at $9.23 per share.


92,300


08/20/2012
16,000


 
Award at $0 per share.


0





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Dr. Clay B. Siegall 
Chairman, President & Chief Executive Officer




Mr. Eric L. Dobmeier 
Chief Operating Officer




Mr. Todd E. Simpson 
Chief Financial Officer




Dr. Vaughn B. Himes 
Chief Technology Officer




Dr. Jonathan  Drachman 
Chief Medical Officer, EVP-Research & Development




Dr. Robert J. Lechleider 
Senior Vice President-Clinical Development




Mr. Darren S. Cline 
Executive Vice President-Commercial




Ms. Tricia  Larson 
Head-Product & Pipeline




Dr. Dennis  Benjamin 
Senior Vice President-Translational Research




Dr. Dana  Kennedy 
Executive Medical Director




Dr. Peter D. Senter 
Vice President-Chemistry




Ms. Peggy  Pinkston 
Vice President-Investor Relations




Ms. Brandi  Robinson 
Senior VP-Corporate Communications




Mr. Christopher  Pawlowicz 
Executive Vice President-Human Resources




Ms. Jean I. Liu 
Executive VP-Legal Affairs & General Counsel




Dr. Elaine  Waller 
Executive Vice President-Regulatory Affairs




Dr. Marc E. Lippman 
Independent Director




Mr. John A. Orwin 
Independent Director




Dr. Srinivas  Akkaraju 
Independent Director




Mr. David W. Gryska 
Independent Director




Dr. Felix James Baker 
Lead Independent Director




Mr. Daniel G. Welch 
Independent Director




Dr. Nancy A. Simonian 
Independent Director
















Log In




9:59 PM EDT
July 28, 2017


/marketstate/country/us
New York

	Closed


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
9:16pWall Street isn’t ready for a 1,100-point tumble in the Dow industrials
7:39pBarron's Buzz: Robo 2.0, Facebook and Twitter, Trading On News
7:29pA Wild Week in Washington 
6:32pThe dark side of cruises
6:32pThe highest paid athletes in the world, in one chart
6:31pO.J. Simpson made over $400,000 while in prison and won’t have to give any of it to the Goldman family
6:31p Trump to Police: 'Don't Be Too Nice'
6:31pHere are 10 co-workers you should avoid like the plague — especially in meetings
6:29pTop 10 most annoying people you may want to unfriend on Facebook 
6:29pThis is one person you should never unfriend on Facebook...
6:29p3 horrible ways typos could alter the course of your life
6:27pPaint your bathroom this color and boost your home’s selling price by $5,400
6:27pAmericans’ new badge of honor: ‘I was blocked by a celebrity!’
6:27p5 weird things I found out about America in my first 24 hours 
6:14pBeyond Tesla: 7 stocks driving the autonomous car revolution
6:14pThese 7 highly taxed companies need Congress to finally act on tax reform
6:11pWatch out: ‘Kids’ are making the most money in this stock market 
6:10p7 real ways for millennials to save money (not by brownbagging and skipping Starbucks)
6:09p‘Game of Thrones’: This computer model predicts who will be killed off — or survive
6:09pThis basic balanced index fund is beating the hedge fund averages
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,830.31

+33.76
+0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,374.68

-7.51
-0.12%





s&p 500

/quotes/zigman/3870025/realtime
2,472.10

-3.32
-0.13%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15

























































Vaughn B Himes - Issaquah, WA | Intelius



























Sign In



We found Vaughn B Himes in Issaquah, WA


Vaughn B Himes

                                                                           Intelius found that Vaughn B Himes  is  a male between 50 and 60 years old from Issaquah, WA.  We have connected them to
                10 addresses,
                8 phones,
                and 1 relative or associate.
         





Also Known As

Vaughn Bentley Himes


Get Report Now

Age

Vaughn B Himes is in his 50s

Vaughn Has Lived In

Issaquah, WA
Lincoln Park, NJ
New Hope, PA

Vaughn's Relatives

Martie Bohn







Vaughn B Himes



Zodiac SignScorpio



GenderMale



Professional Status
Executive Vice President Technical Operation at Seattle Genetics , Inc.



Get Report Now










Want to know more about Vaughn? Get a comprehensive background report, find full phone numbers, and other contact information when available, all from billions of available public records.
            Continue below for more details about Vaughn, or use our people search engine to find others.
Get Background Check on Vaughn B Himes
Get a Criminal Check on Vaughn B Himes
Get a Public Record Report on Vaughn B Himes
Get a People Search Report on Vaughn B Himes


Vaughn B Himes's Contact Information
Known Cities Lived In
Find out where Vaughn B Himes has lived as well as Vaughn B Himes's phone numbers and email addresses.




Vaughn B Himes Has Lived in 4 States
Washington Address for Vaughn B Himes


650 M* O****** D* N* 

Issaquah, WA


Has Lived In

Issaquah, WA
Lincoln Park, NJ


Get Full Address Report










Phone Numbers Associated with Vaughn B Himes

(425) ***-**** - Issaquah, WA 
(425) ***-**** - Bothell, WA 
(425) ***-**** - Bothell, WA 


Get Full Phone Report



Email Addresses Associated with Vaughn B Himes

v*********s@***.com
v****s@***.com
v****s@***.com


Get Email Report




Vaughn B Himes's Professional Information
Information regarding Vaughn B Himes's professional history.  Find out previous places Vaughn B Himes has worked as well as dates employed.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Vaughn B Himes Has Worked at 4 Places
Company: Seattle Genetics , Inc.
               Title: Executive Vice President Technical Operation
Company: Targeted Genetics Corporation
               Title: Vice President Manufacturing and Operations
Vaughn B Himes's Experience
Title: Executive Vice President Technical Operation
               Company: Seattle Genetics , Inc.
Job Details
               Company Size: $250 mil to less than $500 mil - Employee Range: 500 to less than 1,000
Title: Vice President Manufacturing and Operations
               Company: Targeted Genetics Corporation
Job Details
               Company Size: Less than $1 mil
Additional Professional Information on Vaughn B Himes

 See Vaughn B Himes's LinkedIn Profile



Vaughn B Himes's Social Network and Potential Email Matches
Find out potential social network profiles and potential email usernamed for Vaughn B Himes


Vaughn B Himes's known Social Networks And Potential Email Matches

Find all of Vaughn B Himes's Social Network Profiles

Get Full Report

Search Social Networks
Including Facebook, LinkedIn, MySpace, Google, Twitter, Yahoo, Jigsaw, ZoomInfo and more



Potential Email Matches
Vaughn Himes
Username Matches

                  VaughnHimes
                  HimesVaughn
                  Vaughn.Himes
                  Himes.Vaughn
                  Vaughn_Himes
                  Himes_Vaughn
                  Vaughn-Himes
                  Himes-Vaughn
                  VHimes
               


Popular Email Services

@gmail.com
@aol.com
@yahoo.com
@comcast.net
@hotmail.com
@msn.com
@rocketmail.com
@att.net
@sbcglobal.net
@ymail.com
@facebook.com
@mail.com
@bellsouth.net
@live.com
@earthlink.net
@cox.net
@prodigy.net
@me.com
@peoplepc.com
@juno.com
@rediffmail.com
@mindspring.com
@comcast.com
@charter.net
@outlook.com




All trademarks, product names, company names or logos on this page are the property of their respective owners.
Related People Searches
V Himes







         Intelius is a leading provider of public data about people and their connections to others. Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the Fair Credit Reporting Act (FCRA). This site should not be used to determine an individual’s eligibility for credit, insurance, employment, housing or any other purpose covered by the FCRA. For employment or tenant screening services, please visit our partner Talentwise.
      

About Us
Site Map
About Our Reports
Blog
Help
Contact Us

© 2003 – 2017 PeopleConnect, Inc. d/b/a Intelius. All Rights Reserved.
         Privacy Policy - UPDATED
Terms of Service - UPDATED






What is the FCRA?
The Fair Credit Reporting Act ("FCRA") is a federal law that promotes the accuracy, fairness and privacy of information in the files of consumer reporting agencies.
Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the FCRA. Intelius reports cannot be used for background checks related to consumer credit, insurance, employment, housing or any other purpose
                  prohibited under the FCRA.
You may not use any information obtained from Intelius for any purpose covered by the FCRA.
Find out more about the FCRA here.













Vaughn B. Himes, PhD - Biography

















































































Log in






E-mail



Password







Remember




Forgot password ?









Become a member for free
Sign up





Sign up




New memberSign up for FREE


New customerDiscover our portfolios












 United States
 United Kingdom
 France
 Deutschland
 Schweiz (DE)
 Suisse (FR)










Settings

            Dynamic quotes 


OFFON

















Markets
Equities
North AmericaEuropeAsiaOceaniaMiddle East» More Equities

Indexes
DOW JONESS&P 500NASDAQ 100TSX COMPFTSE 100» More Indexes

Currency / Forex
EUR / USDGBP / USDUSD / JPYUSD / CADAUD / USD» More Currencies

Commodities
GOLDCrude Oil (WTI)Crude Oil (BRENT)SILVERPLATINUM» More Commodities


 News
Latest News
CompaniesMarketsEconomyCurrency / ForexCommoditiesInterest RatesBusiness LeadersFinancial calendarEconomic calendar

Listed company
Analyst reco.RumorsIPOsCapital Markets TransactionsNew ContractsProfits warningsAppointmentsPress ReleasesEventsCorporate actions

Sector News
EnergyBasic MaterialsIndustrialsConsumer CyclicalConsumer Non-CyclicalFinancialsHealthcareTechnologyTelecommunications ServicesUtilities


 Analysis
All AnalysisCommentariesIndex AnalysisStock Trading StrategiesCommodity AnalysisForex Analysis

 Stock Picks
All stock picks

 Portfolios
My Portfolio
Virtual portfolios
4-Traders Portfolios
European PortfolioUSA PortfolioAsian Portfolio


 Screeners
Market Screener HomeFundamental Analyse
Top Investor RatingTop Trading RatingTop ConsensusGrowth stocksYield stocksLow valuations

Technical Analysis
Oversold stocksOverbought stocksClose to resistancesClose to supportsAccumulation phaseMost volatile stocks


 Watchlists
My Watchlists
Watchlists
Top Lists
Yield stocksGrowth stocksUndervalued Stocks


 Top / Flop
Top News
Most Read NewsHot News

Top Fundamentals
Top CapitalizationTop YieldTop PERTop ConsensusTop Fundamentals

Top Technicals
Top RSIUnusual volumesTop GapsTop STIM

Top Movers
Top USATop CanadaTop U.K.Top GermanyTop EuropeTop Asia


 Tools
Market ScreenerDynamic chartFinancial calendarEconomic calendarSector researchCurrency converter

 Our Services
Premium AccessDiscover our Services

 



















 






4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography


Business Leaders




Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors HomeAll newsMost read newsBusiness Leaders Biography


 
















Vaughn B. Himes, PhD

Age : 56Public asset : 7,827,382 USDLinked companies :  Seattle Genetics, Inc. 





Summary 



Dr. Vaughn B. Himes is Chief Technology Officer at Seattle Genetics, Inc. Dr. Himes was previously employed as Senior Vice President-Technical Operations by ZymoGenetics, Inc., Vice President-Worldwide Manufacturing by Corixa Corp., Vice President-Manufacturing Operations by Targeted Genetics Corp., and Vice President-Product Development by Genovo, Inc.He received his undergraduate degree from Pomona College and a doctorate degree from the University of Minnesota.



Current positions of Vaughn B. Himes, PhD 









 NameTitle
Since
 Seattle Genetics, Inc.(Biotechnology & Medical Research)
Chief Technology Officer
2009



Holdings of Vaughn B. Himes, PhD 










 NameEquities%Valuation

 Seattle Genetics, Inc. (SGEN) Biotechnology & Medical Research 151,2830.11%7,827,382 USD



Vaughn B. Himes, PhD: Personal Network 







 NameLinked companies

Felix James Baker Seattle Genetics, Inc. 

Srinivas Akkaraju Seattle Genetics, Inc. 

Jean I. Liu Seattle Genetics, Inc. 

David W. Gryska Seattle Genetics, Inc. 

Clay B. Siegall Seattle Genetics, Inc. 

Peter D. Senter Seattle Genetics, Inc. 

Marc E. Lippman Seattle Genetics, Inc. 

Eric L. Dobmeier Seattle Genetics, Inc. 

Daniel G. Welch Seattle Genetics, Inc. 

Todd E. Simpson Seattle Genetics, Inc. 




Most Read News 




07/27 LI KA-SHING : Li Ka-shing's CKI to buy German energy metering firm Ista



07/26DJBERNARD ARNAULT : LVMH's Profit Rises 24% in First Half



07/27 RUPERT MURDOCH : As Murdoch waits, Sky cuts operating costs to protect profits



07/26DJMEG WHITMAN : Meg Whitman Steps Down From HP Board



07/28DJNELSON PELTZ : Procter & Gamble, Peltz Spar on Results -- WSJ



07/28 CARLOS SLIM : Hutchison's Drei buys Tele2 to rival Carlos Slim in Austria



07/26DJDAVID SIMON : Executive Pay Falls for Big Mall Owners as Retail Storm Rages On



07/27DJJEFF BEZOS : Amazon's Jeff Bezos Becomes World's Richest Person



07/28DJELON MUSK : Top Company News of the Day



07/22DJWILBUR ROSS : More Cross-Border Commerce



More news

 


            © 2017 People and Ownership :    









Advertisement








Vaughn B. Himes, PhD : Connections 



 Seattle Genetics, Inc.









Felix James BakerSrinivas AkkarajuJean I. LiuDavid W. GryskaClay B. SiegallPeter D. SenterMarc E. LippmanEric L. DobmeierDaniel G. WelchTodd E. Simpson




 Genomic Health, Inc.









Felix James Baker




 Aquinox Pharmaceuticals Inc









Todd E. Simpson




 Alexion Pharmaceuticals, Inc.









Felix James Baker




 Incyte Corporation









David W. Gryska




 Stemline Therapeutics Inc









Eric L. Dobmeier




 Atara Biotherapeutics Inc









Eric L. Dobmeier




 Syros Pharmaceuticals Inc









Srinivas Akkaraju




 Intercept Pharmaceuticals Inc









Srinivas AkkarajuDaniel G. Welch




 Versartis Inc









Srinivas AkkarajuEric L. Dobmeier




 aTyr Pharma Inc









Srinivas Akkaraju




 AveXis Inc









Daniel G. Welch




 Alder Biopharmaceuticals Inc









Clay B. Siegall




 Ultragenyx Pharmaceutical Inc









Clay B. SiegallDaniel G. Welch




 PDL BioPharma Inc









David W. Gryska




Samsara Biocapital, LLC
                                            








Srinivas Akkaraju





The George Institute for Global Health
                                            








Srinivas Akkaraju





Principia Biopharma, Inc.
                                            








Srinivas Akkaraju





Biotechnology Innovation Organization
                                            








Clay B. Siegall





Pacific Northwest Research Institute, Inc.
                                            








Clay B. Siegall





 







Popular Business Leaders 


 

Bernard Arnault
Mary Barra
Luc Besson
Jeff Bezos
Lloyd Blankfein
Michael Bloomberg
Yannick Bolloré
Warren Buffett
Jean-paul Clozel
Gary Cohn
Marc De Lacharrière
Jamie Dimon
Ralph Dommermuth
Sebastian Ebel
John Edwards
David Einhorn
Jeff Fettig
Mark Fields
Carlos Ghosn
David Henry
Carl Icahn
Li Ka-shing
Michel Landel
Daniel Loeb
Jack Ma
Lakshmi Mittal
Rupert Murdoch
Elon Musk
Peter Nicholas
Xavier Niel
John Paulson
Nelson Peltz
Georges Plassat
Hasso Plattner
Thomas Rabe
Giuseppe Recchi
Wolfgang Reitzle
Wilbur Ross
Charles Schwab
Igor Sechin
Carlos Slim
Pascal Soriot
George Soros
Rupert Stadler
Bernard Tapie
John Williamson
Thomas Wilson
Dieter Zetsche
Mark Zuckerberg



A-Z Business Leaders




 



























4-traders.com :MarketsNewsAnalysisStock PicksPortfoliosScreenersWatchlistsTop / FlopToolsOur ServicesAbout :Surperformance SASContact usAdvertiseLegal informationsAbout usStay Connected :FacebookTwitterPartners :Börse: Aktien, Kurse und NachrichtenBest tweets 




   Copyright © 2017 Surperformance. All rights reserved.  












 














Slave














Vaughn B. Himes Ph.D. - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In




















Vaughn B. Himes Ph.D.
Chief Technical Officer at Seattle Genetics, Inc.


View Full Profile
Are you Vaughn B. Himes Ph.D.? Claim your profile


 


Sign up for Equilar Atlas and view Vaughn B. Himes Ph.D.'s full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Vaughn B. Himes Ph.D.'s  network and community.
												FOLLOW changes in Vaughn B. Himes Ph.D.'s employment and money-in-motion.
												CONNECT with Vaughn B. Himes Ph.D. through your network of contacts.
												








Vaughn B. Himes Ph.D.'s Executive Work History


Current


Chief Technical Officer, 
Seattle Genetics, Inc.


Past
To view Vaughn B. Himes Ph.D.'s complete executive work history, sign up now
Age
56

 
 


Vaughn B. Himes Ph.D.'s Biography



Dr. Himes has served as our Chief Technical Officer since August 2016. Dr. Himes joined Seattle Genetics as Executive Vice President, Technical Operations in April 2009 and served as our Executive Vice President, Technical Operations and Process Science from July 2012 until August 2016. Previously, Dr. Himes was with ZymoGenetics, Inc. from November 2005 to March 2009, most recently as Senior Vice President, Technical Operations where his responsibilities included commercial and clinical manufacturing, supply chain and logistics, quality control and process development. From March 2003 to October 2005, he was Vice President, Manufacturing at  ...
(Read More)

			Dr. Himes has served as our Chief Technical Officer since August 2016. Dr. Himes joined Seattle Genetics as Executive Vice President, Technical Operations in April 2009 and served as our Executive Vice President, Technical Operations and Process Science from July 2012 until August 2016. Previously, Dr. Himes was with ZymoGenetics, Inc. from November 2005 to March 2009, most recently as Senior Vice President, Technical Operations where his responsibilities included commercial and clinical manufacturing, supply chain and logistics, quality control and process development. From March 2003 to October 2005, he was Vice President, Manufacturing at Corixa, Inc. Prior to that, he held Vice President positions in manufacturing and development at Targeted Genetics and Genovo. Dr. Himes received a Bachelor of Arts in Chemistry from Pomona College in California and a Ph.D. in Chemical Engineering from the University of Minnesota.
		
Source: Seattle Genetics, Inc. on 04/05/2017
		
	

 






Sign up for Equilar Atlas and view Vaughn B. Himes Ph.D.'s full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Vaughn B. Himes Ph.D.. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Vaughn B. Himes Ph.D.'s  network and community.
												FOLLOW changes in Vaughn B. Himes Ph.D.'s employment and money-in-motion.
												CONNECT with Vaughn B. Himes Ph.D. through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Vaughn B. Himes Ph.D.


















Vaughn B. Himes Ph.D.'s Connections (56)





Sign up now to view Vaughn B. Himes Ph.D.'s 56 connections »









Eric L. Dobmeier
Chief Operating Officer, Seattle Genetics, Inc.









James A. Johnson
Board Member, The Goldman Sachs Group, Inc.









Srinivas Akkaraju
Board Member, Seattle Genetics, Inc.









Bruce L. Carter
Non-Executive Chairman of the Board, Enanta Pharmaceuticals, Inc.









Todd E. Simpson
Chief Financial Officer, Seattle Genetics, Inc.









John A. Orwin
Dir., President and Chief Executive Officer, Relypsa, Inc.









Clay B. Siegall
President, Chief Executive Officer and Chairman of the Board, Seattle Genetics, Inc.









Jonathan G. Drachman
Chief Medical Officer and Executive Vice President, Research and Development, Seattle Genetics, Inc.









Eleanor L. Ramos
Former Chief Medical Officer, Global Blood Therapeutics, Inc.









Nancy A. Simonian
Dir., President and Chief Executive Officer, Syros Pharmaceuticals, Inc.








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Carl G. Annessa
EVP and COO, Hornbeck Offshore Services, Inc.









Elon R. Musk
CEO and Chairman, Tesla









Michael C. Montgomery
Board Member, NMI Holdings, Inc.












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

ï¿½ 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993






















Vaughn B. Himes Ph.D. - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In




















Vaughn B. Himes Ph.D.
Chief Technical Officer at Seattle Genetics, Inc.


View Full Profile
Are you Vaughn B. Himes Ph.D.? Claim your profile


 


Sign up for Equilar Atlas and view Vaughn B. Himes Ph.D.'s full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Vaughn B. Himes Ph.D.'s  network and community.
												FOLLOW changes in Vaughn B. Himes Ph.D.'s employment and money-in-motion.
												CONNECT with Vaughn B. Himes Ph.D. through your network of contacts.
												








Vaughn B. Himes Ph.D.'s Executive Work History


Current


Chief Technical Officer, 
Seattle Genetics, Inc.


Past
To view Vaughn B. Himes Ph.D.'s complete executive work history, sign up now
Age
56

 
 


Vaughn B. Himes Ph.D.'s Biography



Dr. Himes has served as our Chief Technical Officer since August 2016. Dr. Himes joined Seattle Genetics as Executive Vice President, Technical Operations in April 2009 and served as our Executive Vice President, Technical Operations and Process Science from July 2012 until August 2016. Previously, Dr. Himes was with ZymoGenetics, Inc. from November 2005 to March 2009, most recently as Senior Vice President, Technical Operations where his responsibilities included commercial and clinical manufacturing, supply chain and logistics, quality control and process development. From March 2003 to October 2005, he was Vice President, Manufacturing at  ...
(Read More)

			Dr. Himes has served as our Chief Technical Officer since August 2016. Dr. Himes joined Seattle Genetics as Executive Vice President, Technical Operations in April 2009 and served as our Executive Vice President, Technical Operations and Process Science from July 2012 until August 2016. Previously, Dr. Himes was with ZymoGenetics, Inc. from November 2005 to March 2009, most recently as Senior Vice President, Technical Operations where his responsibilities included commercial and clinical manufacturing, supply chain and logistics, quality control and process development. From March 2003 to October 2005, he was Vice President, Manufacturing at Corixa, Inc. Prior to that, he held Vice President positions in manufacturing and development at Targeted Genetics and Genovo. Dr. Himes received a Bachelor of Arts in Chemistry from Pomona College in California and a Ph.D. in Chemical Engineering from the University of Minnesota.
		
Source: Seattle Genetics, Inc. on 04/05/2017
		
	

 






Sign up for Equilar Atlas and view Vaughn B. Himes Ph.D.'s full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Vaughn B. Himes Ph.D.. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Vaughn B. Himes Ph.D.'s  network and community.
												FOLLOW changes in Vaughn B. Himes Ph.D.'s employment and money-in-motion.
												CONNECT with Vaughn B. Himes Ph.D. through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Vaughn B. Himes Ph.D.


















Vaughn B. Himes Ph.D.'s Connections (56)





Sign up now to view Vaughn B. Himes Ph.D.'s 56 connections »









Eric L. Dobmeier
Chief Operating Officer, Seattle Genetics, Inc.









James A. Johnson
Board Member, The Goldman Sachs Group, Inc.









Srinivas Akkaraju
Board Member, Seattle Genetics, Inc.









Bruce L. Carter
Non-Executive Chairman of the Board, Enanta Pharmaceuticals, Inc.









Todd E. Simpson
Chief Financial Officer, Seattle Genetics, Inc.









John A. Orwin
Dir., President and Chief Executive Officer, Relypsa, Inc.









Clay B. Siegall
President, Chief Executive Officer and Chairman of the Board, Seattle Genetics, Inc.









Jonathan G. Drachman
Chief Medical Officer and Executive Vice President, Research and Development, Seattle Genetics, Inc.









Eleanor L. Ramos
Former Chief Medical Officer, Global Blood Therapeutics, Inc.









Nancy A. Simonian
Dir., President and Chief Executive Officer, Syros Pharmaceuticals, Inc.








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Carl G. Annessa
EVP and COO, Hornbeck Offshore Services, Inc.









Elon R. Musk
CEO and Chairman, Tesla









Michael C. Montgomery
Board Member, NMI Holdings, Inc.












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

ï¿½ 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993















HIMES-VAUGHN, LLC - MT VERNON, IA - Company Information









 



























Products
Resources
My Account












Talk to a D&B Advisor 
1-800-280-0780 




Business Directory



IA



MT VERNON



Corn



Corn



                            HIMES-VAUGHN, LLC
                                    



 





















H 


HIMES-VAUGHN, LLC
CLAIM THIS BUSINESS



102 PALISADES RD SW MT VERNON, IA 52314
Get Directions



(319) 895-8858





Business Info



 Founded --
 Incorporated IA
 Annual Revenue $210,000.00
 Employee Count 4
 Industries Corn
 Contacts LAWAIN BIERMANN






Contact Business







Your Email Address

Subject:


Message


Send Message





Company Summary


The company is located in Mt Vernon and incorporated in Iowa. Himes-vaughn, Llc specializes in Corn. Himes-vaughn, Llc has 4 employees and estimated revenues of $210,000.00. 









VERIFIED Status:
UNVERIFIED



Address:
UNVERIFIED





LAST VERIFIED:

                                    --
                                



Phone:

                                    UNVERIFIED
                                





Payment Method:
UNVERIFIED


view full report





Similar Businesses Nearby


                                        Our similar businesses nearby shows similar businesses in their industry and region based on information found in their Dun & Bradstreet Credibility Review profile.                                        







Competitive Landscape


                                        Our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their Dun & Bradstreet Credibility Review profile.                                        







Payments Accepted

NO DATA



Hours



                                        Sunday 

                                        

                                                                                            --
                                            
                                        



                                        Monday 

                                        

                                                                                            --
                                            
                                        



                                        Tuesday 

                                        

                                                                                            --
                                            
                                        



                                        Wednesday 

                                        

                                                                                            --
                                            
                                        



                                        Thursday 

                                        

                                                                                            --
                                            
                                        



                                        Friday 

                                        

                                                                                            --
                                            
                                        



                                        Saturday 

                                        

                                                                                            --
                                            
                                        







H

VIEW ADDITIONAL DATA                        
Select from over 115 networks below to view available data about this business. If this data is unavailable or inaccurate and you own or represent this business, click here for more information on how you may be able to correct it. 







Credibility Review





Google





Facebook.com





Yellowbook.com





Bing.com





Yellowpages.com





MerchantCircle





Tele Atlas (TomTom)





Twitter.com





AOL





MapQuest





Yahoo Local





Apple/Siri





Groupon





Hotfrog.com





Comcast.net Search





ReachLocal





Admedia





Dealsplus





Shoptopia.com





Alteryx





Dogtime Media





KSL.com





Sirtune





AmericanTowns.com





Driverside





Kudzu.com





SpecialsAgent.com





Answers.com





eGood





LawInfo.com





spotlikes.com





anywho.com





eGumball





Likeness.com





Spotzot





eServiceLog





MapMyRun





TechnoCom





apartmentguide.com





ezlocal.com





EZToUse.com





Teleroute





AroundMe.com





metropolist.com





Therapists.com





Atlanta NewHomes





FindLaw.com





Time Out New York





Avantar





FindTheBest.com





mojopages.com





B2B Yellowpages





Fivestar Software





MyCityWay.com





TripAdvisor





bckyrd.com





GiftCards.com





MyCoupons.com





beachcalifornia.com





GoLocal247.com





mymove.com





UpMeSocial.com





Belo





GoodInfo





News-Gazette





Nokia





usdirectory.com





Cars.com





Nomao





Centzy.com





hibu





Openlist.com





ChaCha Search





Homeplate.com





OwnLocal.com





VisiKard





challama.com





Homestore





patch.com





Voltari





CityBot





Pelopidas





Vouchd





ClassifiedAds





Hostway





PlaceIQ





WalkScore.com





CloudMade





Hoodoyou





PlanetDiscover.com





WeddingWire.com





PowerProfiles





Where Inc.





Contractors.com





iGoLocal.com





Radiate Media





Wikiocity





CouponMap





Indeed.com





Wimgo.com





CrowdSpot





Innova Electronics





Intellistrand





realtor.com





DataSphere





InTheMO.com





Reply.com





Yellowbot.com





JiWire





Rocket Fuel





YellowPageCity.com





DMV.org





Justclicklocal.com





Dirxion





Keen.com





Zidster.com







Photos














































Business Credit Report
Receive a one-time comprehensive credit report on this company.
get full credit report


Facebook








Twitter








Yelp






































Call 1.800.280.0780 to speak with a D&B Advisor Today!







Customer Resources
Products
Education Center
Business Articles & Insights
Glossary
Contact Us
Customer Support
Communication Preferences
Search for D&B D-U-N-S




Our Company
About Us
Company History
Business Credit History
Careers
Press Releases
News
Success Stories
Hoovers




Our Network
Partners
Affiliates
Blog
Access to Capital
Entrepreneurial Initiative
D&B International
SupplierEdge




Site Links
Business Directory
Site Map
PIPEDA
Privacy Policy
Website Terms of Service
Product License Agreement







© Dun & Bradstreet, Inc. 2017. All rights reserved.

















HIMES VAUGHN B Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      HIMES VAUGHN B
                    

•   BOTHELL, WA
                      
How do I update this listing?




                                             Himes Vaughn B is based out of Bothell.    WhaleWisdom has at least 3 insider transactions (Form 3,4,5) in our database for Himes Vaughn B. 
                                           














Summary
13D/G
Insider (Form 4)



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from HIMES VAUGHN B, enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




himes vaughn b


C/O SEATTLE GENETICS, INC.

BOTHELL
WA
                                                        
                                                    98021


                                                      Business Phone:
                                                      4255274000
SEC SIC CODE:2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)







Recent SEC Filings




4 filed on 06/02/2017
4 filed on 04/04/2017
4 filed on 12/14/2016
4 filed on 12/08/2016
4 filed on 09/01/2016
4 filed on 08/30/2016
4 filed on 08/22/2016
4 filed on 12/21/2015
4 filed on 12/16/2015
4 filed on 08/25/2015
















Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...








Elevate your investments
Try it for free
























Export.gov - DGM Healthcare Connections Speakers


 




 

 






















 


 

 





 













How To Export


eCommerce
Export Education
Finding Foreign Markets
Legal Considerations
Logistics
Financial Considerations
Product Preparation




Customized Services


Services for U.S. Exporters
Plan and Assess
Promote and Expand
Locations




Market Intelligence


Find Market Intelligence
Export Guides
Trade Leads
Trade Data & Analysis




Events


Events and Trade Missions
Webinars




Trade Problems 

Get Help with Trade Problems
Report a Foreign Trade Barrier
Foreign Trade Remedies
Foreign Safeguard Activity Involving U.S. Exports
U.S. Products Subject to AD/CVD Measures




FAQs


Boards


About Us


International Trade Administration
Federal Trade Partners
Programs for Trade Promotion Partners
Trade Initiatives
Contact Us
Social Media









Home >
				
Discover Global Markets	
				>
Healthcare Connections	
				>
Speakers



Print







Discover Global Markets: Healthcare Connections


Home


Agenda


One-on-One Meetings With U.S. Commercial Diplomats


Speakers


Business-to-Business Matchmaking


Sponsors


Become a Sponsor


Accommodations & Travel


Global Healthcare Resources & Events


Learn About the Discover Global Markets Series





















 

Connect to global healthcare opportunities, regulatory developments, and market intelligence via panels, executive meetings, and networking
Bellevue, WA •  September 13-15, 2016

 


 

 

 

 

Our Speakers 












 Benjamin Arazy
CEO
Arazy Group Consultants Inc.

Charles Barnett
Relationship Manager / Loan Officer
EXIM Bank

Jan Beck
Vice President & Site Head
Novo Nordisk Research Center - Seattle












 Antonio Cabral
Sanctions Licensing Officer
Office of Foreign Assets Control, U.S. Department of Treasury

Greg Caressi
Senior Vice President for Transformational Health
Frost & Sullivan

Corey Casper
Head of Global Oncology
Fred Hutchinson Cancer Research Center












 Lisa Cohen
Executive Director 
Washington Global Health Alliance

Peter Coronado
Director of Regulatory Affairs
Varian Medical Systems

Guillame Corpart
Managing Director
Global Health Intelligence












 Juliana Cyril
Director, Technology Transfer & Innovation Office
Centers for Disease Control and Prevention (CDC)

Steve Davis
CEO
PATH

Andy De
MD & Global GM, Healthcare and Life Sciences
Tableau Software












 Verinda Fike
Country Manager, East Asia
U.S. Trade And Development Agency

Sarah Fitt
Director of Operations
PHARMAC

Ralph Foster
Managing Partner / VP Strategy and Business Development
Exegete Healthcare International












 Barry Friedman
Chief of Clinical Global Services
Minnesota International Medicine

Rowena Gates
VP Business Development
Eng3 Corporation

Michael Gropp
Former Medical Technology International Regulatory Policy Executive












 Trevor Gunn
Vice President, International Relations
Medtronic, Inc.

Tara Hart
CEO
IOPI Medical LLC

James B. Hendricks
President
Seattle Children’s Research Institute












 Vaughn Himes
Executive VP, Process Sciences and Technical Operations
Seattle Genetics

Ken Hyatt
Acting Under Secretary for International Trade
U.S. Department of Commerce

Neil Jordan
General Manager, Worldwide Health
Microsoft Corp.












 Murali Karamchedu
CTO
Enli Health Intelligence

Ravi Kiron
Managing Partner
BioPharma Strategy Advisors, Inc.

Eder Lagermann
International Research Director
KLAS Research












 Aura Lopez
General Manager for Business Development
Cleveland Clinic

Gary Makowski
Principal
AsiaMed Associates LLC

Brett McMillen
General Manager, Civilian Government
Amazon Web Services, Amazon.com












 Diane Mooney
Director, U.S. Commercial
 Service, Seattle
U.S. Department of Commerce

Gemma Moore
Vice President of Global
Regulatory Affairs
Edwards Lifesciences

Trevor Mundel
President, Global Health Division
Bill & Melinda Gates Foundation












 Lina Kwee-Nguyen
Manager, Market Access Group in North America
TUV Rheinland of North America

Eliana Silve de Moraes
Lawyer
International Food and Drug Law

Noah Perin
Founder and CEO
VIA Global Health












 Marc Perlman
Managing Director and Global Business Development Leader
Deloitte LLC

Jacob Plummer
Global Operations and Business Development
Allscripts

Grant Ramaley
Director of Regulatory Affairs
Aseptico Inc.












 Judy Rising Reinke
Deputy Director General, U.S. Commercial Service
U.S. Department of Commerce

Karin Rodland
Laboratory Fellow, Biological Sciences Division
Pacific Northwest National Laboratory

Joel Rydbeck
Director of Global Business Development
Infor Healthcare












 Tembi Secrist
Director, Global Healthcare Team, U.S. Commercial Service
U.S. Department of Commerce

Ken Silverman
Head, North America
Sannam S4 Group / U.S. Business Centers

Christopher Swift
Senior Counsel, Export Controls & Nat’l Security
Foley & Lardner, LLP












 Jordan Tappero
Rear Admiral, Senior Advisor for Global Health
Centers for Disease Control and Prevention (CDC)

Scott Thielman
Chief Technology Officer
Product Creation Studio

Maurizio Vecchione
Sr. Vice President of Global Good & Research
Intellectual Ventures












 Daryl Wisdahl
Managing Director Canada
Emergo

Mark Wen
Vice President & Director
Seattle Children’s Hospital

Jon Zimmerman
Vice President and General Manager
GE Healthcare







 

 


 Drew Zwiebel
Vice President Global
 Alliances & Channels
Oracle

 

 





 

 

 


 

 

 



 




 
 




 






 
 



 
 

 
Print
				               				|
											Last Updated: 9/13/16 7:48 PM








How To Export

eCommerce
Export Education
Finding Foreign Markets
Legal Considerations
Logistics
Financial Considerations
Product Preparation

Customized Services

Services for U.S. Exporters
Plan and Assess
Promote and Expand
Locations



Market Intelligence

Find Market Intelligence
Export Guides
Trade Leads
Trade Data & Analysis

Events

Events and Trade Missions
Webinars

Trade Problems

Get Help with Trade Problems
Report a Foreign Trade Barrier
Foreign Trade Remedies
Foreign Safeguard Activity Involving U.S. Exports
U.S. Products Subject to AD/CVD Measures



FAQs
Boards
About Us

International Trade Administration
Federal Trade Partners
Programs for Trade Promotion Partners
Trade Initiatives
Contact Us
Social Media





Submit Feedback
				    |
				    Contact Us 
				    |
					Social Media
				    |
					Privacy Policy
					|
					FOIA					
				    |
				    Disclaimer
				    |
				    About Us
				    |				    
				    USA.gov

				    |
               		Download Adobe Reader









  Notice to Visitors! 

  The link you have chosen will take you to a non-U.S. Government website. 
  If the page does not appear in 5 seconds, please click this: outside web site
  Export.gov is managed by the International Trade Administration and
external links are covered by its website  disclaimer statement.



  Notice to Visitors! 

  The link you have chosen will take you to a non-U.S. Government website. 
  If the page does not appear in 5 seconds, please click this: outside web site
  BuyUSA.gov is managed by the International Trade Administration and
external links are covered by its website disclaimer statement.













Export.gov - Connect to global healthcare opportunities, regulatory developments, and market 


 




 

 






















 


 

 





 













How To Export


eCommerce
Export Education
Finding Foreign Markets
Legal Considerations
Logistics
Financial Considerations
Product Preparation




Customized Services


Services for U.S. Exporters
Plan and Assess
Promote and Expand
Locations




Market Intelligence


Find Market Intelligence
Export Guides
Trade Leads
Trade Data & Analysis




Events


Events and Trade Missions
Webinars




Trade Problems 

Get Help with Trade Problems
Report a Foreign Trade Barrier
Foreign Trade Remedies
Foreign Safeguard Activity Involving U.S. Exports
U.S. Products Subject to AD/CVD Measures




FAQs


Boards


About Us


International Trade Administration
Federal Trade Partners
Programs for Trade Promotion Partners
Trade Initiatives
Contact Us
Social Media









Home >
				
Discover Global Markets	
				>
Healthcare Connections



Print







Discover Global Markets: Healthcare Connections


Home


Agenda


One-on-One Meetings With U.S. Commercial Diplomats


Speakers


Business-to-Business Matchmaking


Sponsors


Become a Sponsor


Accommodations & Travel


Global Healthcare Resources & Events


Learn About the Discover Global Markets Series
























 

Connect to global healthcare opportunities, regulatory developments, and market intelligence via panels, executive meetings, and networking
Bellevue, WA • September 13-15, 2016

 


 

 

 


 



  

 


 


Discover Global Markets: Healthcare Connections is the must-attend event of the year!  Featuring global updates on the medical device, diagnostics, health IT, and global health sectors, this conference will equip you to compete and win internationally. You will hear directly from industry leaders on project opportunities and regulations, connect with international buyers, network with healthcare companies from around the country and get up-to-the-minute market intelligence from our U.S. Embassy-based industry specialists.  It’s an event you won’t want to miss!


 


One-on-One Consultations with U.S. Commercial Diplomats:
Meet with in-country U.S. Commercial Diplomats and Specialists. Gain customized market intelligence to position your firm for success in 20+ markets, including:


 


*Country list is subject to change.


 Argentina
 Australia
 Brazil
 Canada
 China
 Colombia
 Central America
 European Union

 Germany
 India
 Israel
 Jordan
 Kenya
 Kuwait
 Malaysia

 Mexico 
 Nordics 
 Qatar
 Saudi Arabia
 Singapore
 Serbia
 Vietnam



Who Should Attend? 


 C-level executives responsible for understanding the global outlook for the industry and upcoming market opportunities
 Sales and marketing professionals responsible for acting quickly on market demands, foreign tenders, and trade leads
 Regulatory professionals responsible for understanding country approval frameworks
 Investors and professional advisors




State Incentive Programs May Be Available




Check with your state trade office to learn if there are STEP grants available to apply toward Discover Global Markets registration.




California Companies: STEP grants are available to qualified companies. 
Learn More and Register.



Washington Companies: Washington State is offering Vouchers covering up to 75% of the registration fee to qualifying small businesses, to help defray the cost of attending. Learn More and Apply.  



Oregon Companies: STEP grants are available to help cover costs of participating in Healthcare Connections. Learn More and Register.


 

 


For More Global Market Information and Events


For more global market information and events, please visit our Healthcare Industry page.







 


Download the full video (MB)


 

 





 


For more information:


Tembi Secrist
(206) 553-5615, ext. 229
Tembi.Secrist@trade.gov

Diane Mooney
(206) 553.5615, ext. 236
Diane.Mooney@trade.gov


 

 


 




 
 




 






 









 
 

 
Print
				               				|
											Last Updated: 9/13/16 7:45 PM








How To Export

eCommerce
Export Education
Finding Foreign Markets
Legal Considerations
Logistics
Financial Considerations
Product Preparation

Customized Services

Services for U.S. Exporters
Plan and Assess
Promote and Expand
Locations



Market Intelligence

Find Market Intelligence
Export Guides
Trade Leads
Trade Data & Analysis

Events

Events and Trade Missions
Webinars

Trade Problems

Get Help with Trade Problems
Report a Foreign Trade Barrier
Foreign Trade Remedies
Foreign Safeguard Activity Involving U.S. Exports
U.S. Products Subject to AD/CVD Measures



FAQs
Boards
About Us

International Trade Administration
Federal Trade Partners
Programs for Trade Promotion Partners
Trade Initiatives
Contact Us
Social Media





Submit Feedback
				    |
				    Contact Us 
				    |
					Social Media
				    |
					Privacy Policy
					|
					FOIA					
				    |
				    Disclaimer
				    |
				    About Us
				    |				    
				    USA.gov

				    |
               		Download Adobe Reader









  Notice to Visitors! 

  The link you have chosen will take you to a non-U.S. Government website. 
  If the page does not appear in 5 seconds, please click this: outside web site
  Export.gov is managed by the International Trade Administration and
external links are covered by its website  disclaimer statement.



  Notice to Visitors! 

  The link you have chosen will take you to a non-U.S. Government website. 
  If the page does not appear in 5 seconds, please click this: outside web site
  BuyUSA.gov is managed by the International Trade Administration and
external links are covered by its website disclaimer statement.













Export.gov - Vaughn Himes


 




 

 






















 


 

 





 













How To Export


eCommerce
Export Education
Finding Foreign Markets
Legal Considerations
Logistics
Financial Considerations
Product Preparation




Customized Services


Services for U.S. Exporters
Plan and Assess
Promote and Expand
Locations




Market Intelligence


Find Market Intelligence
Export Guides
Trade Leads
Trade Data & Analysis




Events


Events and Trade Missions
Webinars




Trade Problems 

Get Help with Trade Problems
Report a Foreign Trade Barrier
Foreign Trade Remedies
Foreign Safeguard Activity Involving U.S. Exports
U.S. Products Subject to AD/CVD Measures




FAQs


Boards


About Us


International Trade Administration
Federal Trade Partners
Programs for Trade Promotion Partners
Trade Initiatives
Contact Us
Social Media









Home >
				
Discover Global Markets	
				>
Healthcare Connections	
				>
Speakers



Print







Discover Global Markets: Healthcare Connections


Home


Agenda


One-on-One Meetings With U.S. Commercial Diplomats


Speakers


Business-to-Business Matchmaking


Sponsors


Become a Sponsor


Accommodations & Travel


Global Healthcare Resources & Events


Learn About the Discover Global Markets Series


















Vaughn Himes
Executive VP, Process Sciences and Technical Operations
Seattle Genetics







Vaughn Himes joined Seattle Genetics in 2009, bringing more than twenty years of experience in manufacturing, technical operations, process development and scale-up activities. He oversees manufacturing, supply chain and quality assurance and control functions. Prior to joining Dr. Himes held various executive positions with Zymogenetics, Corixa, Targeted Genetics and Genovo. Dr. Himes received a B.A. in Chemistry from Pomona College and a Ph.D. in Chemical Engineering from the University of Minnesota.


 



 







 
 



 
 

 
Print
				               				|
											Last Updated: 8/10/16 7:26 PM








How To Export

eCommerce
Export Education
Finding Foreign Markets
Legal Considerations
Logistics
Financial Considerations
Product Preparation

Customized Services

Services for U.S. Exporters
Plan and Assess
Promote and Expand
Locations



Market Intelligence

Find Market Intelligence
Export Guides
Trade Leads
Trade Data & Analysis

Events

Events and Trade Missions
Webinars

Trade Problems

Get Help with Trade Problems
Report a Foreign Trade Barrier
Foreign Trade Remedies
Foreign Safeguard Activity Involving U.S. Exports
U.S. Products Subject to AD/CVD Measures



FAQs
Boards
About Us

International Trade Administration
Federal Trade Partners
Programs for Trade Promotion Partners
Trade Initiatives
Contact Us
Social Media





Submit Feedback
				    |
				    Contact Us 
				    |
					Social Media
				    |
					Privacy Policy
					|
					FOIA					
				    |
				    Disclaimer
				    |
				    About Us
				    |				    
				    USA.gov

				    |
               		Download Adobe Reader









  Notice to Visitors! 

  The link you have chosen will take you to a non-U.S. Government website. 
  If the page does not appear in 5 seconds, please click this: outside web site
  Export.gov is managed by the International Trade Administration and
external links are covered by its website  disclaimer statement.



  Notice to Visitors! 

  The link you have chosen will take you to a non-U.S. Government website. 
  If the page does not appear in 5 seconds, please click this: outside web site
  BuyUSA.gov is managed by the International Trade Administration and
external links are covered by its website disclaimer statement.






